Tuomi, T., Carlsson, A., Li, H., Isomaa, B., Miettinen, A., Nilsson, A., Nissen, M., Ehrnstrom, B.O., Forsen, B., Snickars, B., Lahti, K., Forsblom, C., Saloranta, C., Taskinen, M.R. and Groop, L.C. (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes, 48, 150-157. doi:10.2337/diabetes.48.1.150

has been cited by the following article:

• TITLE: Reduced endogenous insulin secretion in diabetic patients with low-titer positive antibodies against GAD

  AUTHORS: Yuichiro Takeuchi, Hiroyuki Ito, Koshiro Oshikiri, Shinichi Antoku, Mariko Abe, Mizuo Mifune, Michiko Togane, Masahiro Kato

  KEYWORDS: GAD Antibody; Endogenous Insulin Secretion; Urinary C-Peptide; SPIDDM; LADA

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.2 No.1, February 22, 2012

  ABSTRACT: Aim: To investigate the clinical characteristics of diabetic patients with a low-titer positive for the anti-glutamic acid decarboxylase 65 antibody (GAD antibody). Methods: The subjects were 420 diabetic inpatients. The endogenous insulin secretion was estimated on the basis of the C-peptide immunoreactivity from a 24 h urine collection (uCPR). Clinical variables were compared between patients negative for the GAD antibody (GAD antibody titer